Smaill F |
Antibiotic susceptibility and resistance testing: an overview. |
2000 |
Can. J. Gastroenterol. |
pmid:11111110
|
Fallone CA |
Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. |
2000 |
Can. J. Gastroenterol. |
pmid:11111111
|
Chiba N |
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens. |
2000 |
Can. J. Gastroenterol. |
pmid:11111112
|
Garey KW et al. |
Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. |
2000 |
Chest |
pmid:11115481
|
Jayasagar G et al. |
Effect of clarithromycin on the pharmacokinetics of tolbutamide. |
2000 |
Drug Metabol Drug Interact |
pmid:11116754
|
Aydin A and Isler M |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. |
2000 |
Clin Ther |
pmid:11117661
|
Fujiwara T et al. |
Helicobacter pylori infection in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:11120026
|
Okhravi N et al. |
Assessment of the effect of oral clarithromycin on visual outcome following presumed bacterial endophthalmitis. |
2000 |
Curr. Eye Res. |
pmid:11120557
|
Ichiyama T et al. |
Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11120942
|
Veldhuyzen Van Zanten S et al. |
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121908
|
Isomoto H et al. |
5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121910
|
Canducci F et al. |
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121911
|
Toracchio S et al. |
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121913
|
Bañuls J et al. |
Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis. |
2000 |
Br. J. Dermatol. |
pmid:11122063
|
Giannopoulos A et al. |
Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis. |
2001 |
J. Urol. |
pmid:11125373
|
Ozkan Y et al. |
Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres. |
2000 Sep-Oct |
Acta Pol Pharm |
pmid:11126029
|
Hizawa K et al. |
Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection. |
2000 |
J. Clin. Gastroenterol. |
pmid:11129280
|
Xiao SD et al. |
A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11136281
|
Fuchs PC et al. |
Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. |
2001 |
J. Clin. Microbiol. |
pmid:11136745
|
Rüssmann H et al. |
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. |
2001 |
J. Clin. Microbiol. |
pmid:11136788
|
Kalach N et al. |
High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. |
2001 |
J. Clin. Microbiol. |
pmid:11136811
|
Osato MS et al. |
Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11137647
|
Sicilia B et al. |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy]. |
2000 |
Med Clin (Barc) |
pmid:11141412
|
Pilotto A et al. |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. |
2000 |
Dig Liver Dis |
pmid:11142574
|
Gascón A et al. |
Catheter salvage in a patient on hemodialysis with a catheter-related bacteremia by Pseudomonas aeruginosa. Usefulness of clarithromycin. |
2000 Nov-Dec |
Am. J. Nephrol. |
pmid:11146320
|
Armuzzi A et al. |
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11148433
|
Chu KM et al. |
One-week once-daily triple therapy for Helicobacter pylori--a pilot study. |
2000 Nov-Dec |
Hepatogastroenterology |
pmid:11149018
|
Laine L et al. |
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. |
2000 |
Am. J. Gastroenterol. |
pmid:11151867
|
Engler KH et al. |
In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae. |
2001 |
J. Antimicrob. Chemother. |
pmid:11152428
|
Fichtenbaum CJ et al. |
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. |
2000 |
AIDS |
pmid:11153670
|
Esposito S et al. |
Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model. |
2000 |
J Chemother |
pmid:11154028
|
Fuentes F et al. |
In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation model. |
2000 |
J Chemother |
pmid:11154032
|
Fanti L et al. |
Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer. |
2001 |
J. Clin. Gastroenterol. |
pmid:11154169
|
Santolaria S et al. |
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication. |
2001 |
J. Clin. Gastroenterol. |
pmid:11154181
|
Matsumura M et al. |
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. |
2001 |
J. Clin. Microbiol. |
pmid:11158129
|
Maggi-Solcà N et al. |
Prevalence of Helicobacter pylori resistant strains in the southern part of Switzerland. |
2000 |
Clin. Microbiol. Infect. |
pmid:11168035
|
Adamsson I et al. |
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection. |
2000 |
Clin. Microbiol. Infect. |
pmid:11168124
|
Ruskoné-Fourmestraux A et al. |
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. |
2001 |
Gut |
pmid:11171816
|
Rosandić M |
Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study. |
2001 |
Croat. Med. J. |
pmid:11172654
|
Mueller PS and Edson RS |
Disseminated Mycobacterium abscessus infection manifesting as fever of unknown origin and intra-abdominal lymphadenitis: case report and literature review. |
2001 |
Diagn. Microbiol. Infect. Dis. |
pmid:11173189
|
Esposito S et al. |
Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae. |
2001 Mar-Apr |
Chemotherapy |
pmid:11173809
|
Armuzzi A et al. |
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. |
2001 |
Digestion |
pmid:11173893
|
Conrad DA |
Treatment of cat-scratch disease. |
2001 |
Curr. Opin. Pediatr. |
pmid:11176245
|
Steele RW et al. |
Compliance issues related to the selection of antibiotic suspensions for children. |
2001 |
Pediatr. Infect. Dis. J. |
pmid:11176558
|
Moayyedi P et al. |
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. |
2000 |
Helicobacter |
pmid:11179985
|
Mégraud F et al. |
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo. |
2000 |
Helicobacter |
pmid:11179987
|
Gisbert JP and MarÃa Pajares J |
[Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review]. |
2001 |
Med Clin (Barc) |
pmid:11181291
|
Wang G et al. |
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11181351
|
Hiyama T et al. |
c-myc gene mutation in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma. |
2001 Mar-Apr |
Oncol. Rep. |
pmid:11182042
|
Hiyama T et al. |
Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication. |
2001 Mar-Apr |
Oncol. Rep. |
pmid:11182043
|
de Luis DA et al. |
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. |
2001 |
Diabetes Res. Clin. Pract. |
pmid:11182211
|
Nightingale CH |
A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel. |
2000 May-Jun |
Adv Ther |
pmid:11183454
|
Sato K et al. |
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. |
2000 |
Int. J. Antimicrob. Agents |
pmid:11185410
|
Taylor DE |
Pathophysiology of antibiotic resistance: clarithromycin. |
2000 |
Can. J. Gastroenterol. |
pmid:11188799
|
Lahaie RG and Gaudreau C |
Helicobacter pylori antibiotic resistance: trends over time. |
2000 |
Can. J. Gastroenterol. |
pmid:11188800
|
Adler JL et al. |
Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis. |
2000 |
Clin Ther |
pmid:11192133
|
Murray JJ et al. |
Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis. |
2000 |
Clin Ther |
pmid:11192134
|
Matsuo K et al. |
[Pulmonary Nocardia otitidiscaviarum infection in an immunocompetent host]. |
2000 |
Nihon Kokyuki Gakkai Zasshi |
pmid:11193319
|
Katelaris PH |
Helicobacter pylori: changing patterns of ulcer disease and antibiotic resistance. |
2000 |
Med. J. Aust. |
pmid:11194729
|
Mollison LC et al. |
Antibiotic resistance in Helicobacter pylori. |
2000 |
Med. J. Aust. |
pmid:11194734
|
Badyal DK and Garg SK |
Effect of clarithromycin on the pharmacokinetics of carbamazepine in rhesus monkeys. |
2000 |
Methods Find Exp Clin Pharmacol |
pmid:11196346
|
Kaipiainen-Seppänen O and Hyvärinen L |
Adverse reactions to rifabutin. |
2001 |
J. Rheumatol. |
pmid:11196537
|
Nomura H et al. |
A short-term eradication therapy for Helicobacter pylori acute gastritis. |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11197046
|
Lee AJ and Maddix DS |
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. |
2001 |
Ann Pharmacother |
pmid:11197581
|
Koizumi T et al. |
[Pulmonary Mycobacterium gordonae infection treated with clarithromycin]. |
2000 |
Kekkaku |
pmid:11201139
|
Felley CP et al. |
Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. |
2001 |
Eur J Gastroenterol Hepatol |
pmid:11204805
|
Bortolotti M et al. |
Effect of clarithromycin on esophageal motility. |
2000 |
Dis. Esophagus |
pmid:11206638
|
Wong BC et al. |
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207516
|
Fakheri H et al. |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207517
|
Nagahara A et al. |
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207518
|
Iakovlev VP et al. |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections]. |
2000 |
Antibiot. Khimioter. |
pmid:11210297
|
Sazykin IuO et al. |
[Clarithromycin and tumor chemotherapy]. |
2000 |
Antibiot. Khimioter. |
pmid:11210301
|
Pilotto A et al. |
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. |
2000 |
Dig Liver Dis |
pmid:11215555
|
Kato M et al. |
[Recent guidelines for the management of Helicobacter pylori infection]. |
2001 |
Nippon Rinsho |
pmid:11218393
|
Inoue K et al. |
[Antimicrobial resistant test of H. pylori]. |
2001 |
Nippon Rinsho |
pmid:11218400
|
Murakami K et al. |
[Selection of antibiotics and planning of eradication for H. pylori infection]. |
2001 |
Nippon Rinsho |
pmid:11218403
|
Tanabe H et al. |
[Usefulness of new triple therapy containing PPI]. |
2001 |
Nippon Rinsho |
pmid:11218404
|
Ohkusa T and Watanabe M |
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment]. |
2001 |
Nippon Rinsho |
pmid:11218406
|
Maeda S and Yoshida H |
[Mechanism of drug resistance in Helicobacter pylori]. |
2001 |
Nippon Rinsho |
pmid:11218414
|
Pijlman AH et al. |
[Acute delirium, probably precipitated by clarithromycin]. |
2001 |
Ned Tijdschr Geneeskd |
pmid:11219151
|
Anzueto A et al. |
Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis. |
2001 |
Clin Ther |
pmid:11219481
|
Gotfried MH et al. |
Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis. |
2001 |
Clin Ther |
pmid:11219483
|
Malik R et al. |
Treatment of canine leproid granuloma syndrome: preliminary findings in seven dogs. |
2001 |
Aust. Vet. J. |
pmid:11221566
|
de Dios GarcÃa-DÃaz J et al. |
[Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin]. |
2001 |
Med Clin (Barc) |
pmid:11222159
|
Wilcox MH |
Clarithromycin and risk of Clostridium difficile-associated diarrhoea. |
2001 |
J. Antimicrob. Chemother. |
pmid:11222572
|
Miki H et al. |
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. |
2001 |
J. Gastroenterol. |
pmid:11227668
|
Kim HS et al. |
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer. |
2001 |
J. Gastroenterol. |
pmid:11227677
|
Kato K et al. |
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. |
2001 |
Gastrointest. Endosc. |
pmid:11231401
|
Maconi G et al. |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? |
2001 |
Am. J. Gastroenterol. |
pmid:11232676
|
Ozluer SM and De'Ambrosis BJ |
Mycobacterium abscessus wound infection. |
2001 |
Australas. J. Dermatol. |
pmid:11233716
|
Ishigo S et al. |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture]. |
2000 |
Jpn J Antibiot |
pmid:11234221
|
Cangelosi GA et al. |
Phenotypic consequences of red-white colony type variation in Mycobacterium avium. |
2001 |
Microbiology (Reading, Engl.) |
pmid:11238960
|
Furuta T et al. |
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. |
2001 |
Clin. Pharmacol. Ther. |
pmid:11240980
|
Yazawa N et al. |
The successful treatment of prurigo pigmentosa with macrolide antibiotics. |
2001 |
Dermatology (Basel) |
pmid:11244235
|
Leung WK and Graham DY |
Clarithromycin for Helicobacter pylori infection. |
2000 |
Expert Opin Pharmacother |
pmid:11249534
|
Amábile-Cuevas CF et al. |
Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. |
2001 |
Clin. Infect. Dis. |
pmid:11249826
|
Schentag JJ et al. |
What have we learned from pharmacokinetic and pharmacodynamic theories? |
2001 |
Clin. Infect. Dis. |
pmid:11249828
|
Krasemann C et al. |
Evaluation of the clinical microbiology profile of moxifloxacin. |
2001 |
Clin. Infect. Dis. |
pmid:11249830
|
Vergassola R et al. |
[Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol]. |
2000 |
Minerva Cardioangiol |
pmid:11253326
|
Bindayna KM |
Antibiotic susceptibilities of Helicobacter pylori. |
2001 |
Saudi Med J |
pmid:11255612
|